Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD.

J Bone Miner Res. 2003 Jun;18(6):1051-6.

2.

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Seibel MJ, Naganathan V, Barton I, Grauer A.

J Bone Miner Res. 2004 Feb;19(2):323-9. Epub 2003 Dec 16.

3.
4.
5.

Risedronate reduces the risk of first vertebral fracture in osteoporotic women.

Heaney RP, Zizic TM, Fogelman I, Olszynski WP, Geusens P, Kasibhatla C, Alsayed N, Isaia G, Davie MW, Chesnut CH 3rd.

Osteoporos Int. 2002;13(6):501-5.

PMID:
12107665
6.

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.

J Bone Miner Res. 2000 Aug;15(8):1526-36.

7.

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P.

J Am Geriatr Soc. 2004 Nov;52(11):1832-9.

PMID:
15507059
8.

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.

Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.

J Bone Miner Res. 1996 Oct;11(10):1531-8.

PMID:
8889854
9.

Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography.

Dufresne TE, Chmielewski PA, Manhart MD, Johnson TD, Borah B.

Calcif Tissue Int. 2003 Nov;73(5):423-32. Epub 2003 Sep 11.

PMID:
12964065
10.

Fracture risk remains reduced one year after discontinuation of risedronate.

Watts NB, Chines A, Olszynski WP, McKeever CD, McClung MR, Zhou X, Grauer A.

Osteoporos Int. 2008 Mar;19(3):365-72. Epub 2007 Oct 16.

PMID:
17938986
11.

Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.

Ohtori S, Akazawa T, Murata Y, Kinoshita T, Yamashita M, Nakagawa K, Inoue G, Nakamura J, Orita S, Ochiai N, Kishida S, Takaso M, Eguchi Y, Yamauchi K, Suzuki M, Aoki Y, Takahashi K.

J Clin Neurosci. 2010 Feb;17(2):209-13. doi: 10.1016/j.jocn.2009.06.013. Epub 2009 Dec 30.

PMID:
20044258
12.

Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate.

Watts NB, Lindsay R, Li Z, Kasibhatla C, Brown J.

Osteoporos Int. 2003 Jun;14(5):437-41. Epub 2003 Apr 29.

PMID:
12730756
13.

Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.

Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S.

Calcif Tissue Int. 2004 Feb;74(2):129-35. Epub 2003 Dec 5.

PMID:
14648009
14.

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.

Garnero P, Aronstein WS, Cohen SB, Conaghan PG, Cline GA, Christiansen C, Beary JF, Meyer JM, Bingham CO 3rd.

Osteoarthritis Cartilage. 2008 Jun;16(6):660-6. Epub 2007 Nov 13.

15.

Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.

Ste-Marie LG, Sod E, Johnson T, Chines A.

Calcif Tissue Int. 2004 Dec;75(6):469-76. Epub 2004 Oct 14.

PMID:
15478000
16.

Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Ettinger MP.

Arch Intern Med. 2003 Oct 13;163(18):2237-46. Review.

PMID:
14557222
18.
19.

Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy.

Kanaji A, Higashi M, Namisato M, Nishio M, Ando K, Yamada H.

Lepr Rev. 2006 Jun;77(2):147-53.

PMID:
16895071
20.

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R.

Osteoporos Int. 2000;11(1):83-91.

PMID:
10663363
Items per page

Supplemental Content

Write to the Help Desk